BlackDoctor.org, Evidation Health, Movember, and Myovant Sciences Launch Forward Momentum Coalition to Increase Diversity in ...
June 30 2020 - 8:30AM
BlackDoctor.org, Evidation Health, Movember, and Myovant Sciences
(NYSE: MYOV) today announced the launch of Forward
Momentum, a cross-sector coalition working on innovative
projects to increase diversity in research and develop new digital
resources for men with prostate cancer.
Prostate cancer is the second most prevalent form of cancer and
second leading cause of cancer death in men in the U.S. More than 3
million men have been diagnosed with prostate cancer in the U.S.
and more than 33,000 deaths are expected in 2020, with Black men
twice as likely to die from the disease. Despite significant
progress in the diagnosis and treatment of prostate cancer, Forward
Momentum believes that collaboration among healthcare, research,
and advocacy organizations is needed to improve the quality of life
and reduce stigma for men with prostate cancer, and to better
understand and address racial disparities in the disease,
especially during the COVID-19 pandemic.
Forward Momentum announced two initial projects aimed at
addressing these issues:
- Increasing Diversity in Health
Research: Evidation is working with
BlackDoctor.org to help Black men and women participate in a study
being conducted in collaboration with Mount Sinai’s Icahn School of
Medicine and the New York City Department of Health and Mental
Hygiene on the effects of COVID-19 on mental health. This is part
of an ongoing effort by Evidation to make health research more
representative and inclusive.
- Digital Resources to Track Mental and Physical Health
in Prostate Cancer: Movember’s True North website helps
men navigate their prostate cancer journey, providing resources,
education, and community. Myovant Sciences is partnering with
Movember to develop novel tools to track mental and physical health
in men with prostate cancer. Since COVID-19 has exacerbated many
men’s health challenges as well as eliminated many of the spaces
that men go to for information and support, Movember and Myovant
Sciences are working to create accessible digital resources
designed to begin to address these issues.
Reggie Ware, chief executive officer of BlackDoctor.org, said,
“Black men and women have historically been under-represented in
scientific and clinical research. Yet, without higher levels of
participation, we cannot effectively investigate the
disproportionate impact of diseases affecting Black communities. We
are proud to use our platform to encourage more members of the
Black community to participate in these important studies and make
their voices heard – particularly around critical healthcare issues
like COVID-19 and prostate cancer.”
Sam Gledhill, global director of digital health at Movember,
said, “Our True North platform is designed to help men navigate
their prostate cancer journey, beyond the cancer itself. We are
committed to creating innovative tools and resources that can help
men track their health and talk about their experiences with the
disease, which can impact all dimensions of their lives. We are
confident that through partnership we can accelerate this
mission.”
Christine Lemke, president and co-founder of Evidation, said,
“Representation truly matters in studies of all kinds. It's
especially critical for diverse voices to be heard and counted
given the disproportionate impact of COVID-19 on communities of
color. We've designed our study to lower the barriers to
participation and capture our collective lived experience of the
pandemic.”
Lynn Seely, M.D., chief executive officer of Myovant
Sciences, said, “Myovant’s mission is to redefine care for men and
for women. To us, that means not only developing new medicines but
sharing our research and expertise in areas like prostate cancer in
order to support initiatives that can improve people’s mental and
physical wellbeing throughout their treatment journey.”
More information is available at forwardmomentum.com.
About BlackDoctor.orgBlackDoctor.org (BDO) is
the leading health and wellness destination for people of color
that leverages culture, content and technology to transform
peoples' lives for the better. With a monthly total audience reach
of 19 million and a heavy emphasis on “how to do it, you can do it”
content, BDO has earned the trust of Black consumers everywhere who
were simply waiting for someone to speak to them with a voice they
can trust and a language they can understand. BDO also boasts the
largest database of culturally sensitive doctors who are committed
to treating all patients fairly, regardless of race or creed. Learn
more about blackdoctor.org at our website and follow us on Twitter
@blackdoctor_org, and Facebook at
http://www.facebook.com/Blackdoctor.org.
About Movember Movember is the leading charity
changing the face of men’s health on a global scale, focusing on
mental health and suicide prevention, prostate cancer and
testicular cancer. The charity raises funds to deliver innovative,
breakthrough research and support programs that enable men to live
happier, healthier and longer lives. Committed to disrupting the
status quo, millions have joined the movement, helping fund over
1,250 projects around the world. In addition to tackling key health
issues faced by men, Movember is working to encourage men to stay
healthy in all areas of their life, with a focus on men staying
socially connected and becoming more open to discussing their
health and significant moments in their lives. The charity’s vision
is to have an everlasting impact on the face of men’s health. To
donate or learn more, please visit Movember.com. Follow us on
Twitter @Movember (USA). Movember is a registered 501(c)(3)
charity.
About Evidation Health Evidation measures
health in everyday life and enables anyone to participate in
ground-breaking research and health programs. Built upon a
foundation of user privacy and control over permissioned health
data, Evidation’s Achievement platform is trusted by millions of
individuals – generating data with unprecedented speed, scale, and
rigor. We partner with leading healthcare companies to understand
health and disease outside the clinic walls. Guided by our mission
to enable and empower everyone to participate in better health
outcomes, Evidation is working to bring people individualized,
proactive, and accessible healthcare—faster. Founded in 2012,
Evidation Health is headquartered in California with additional
offices around the globe. To learn more, visit evidation.com, or
follow us on Twitter @evidation.
About Myovant Sciences Myovant
Sciences aspires to be the leading healthcare company focused
on redefining care for women and for men. The company’s lead
product candidate is relugolix, a once-daily, oral GnRH receptor
antagonist. The company has three late-stage clinical programs
for relugolix in uterine fibroids, endometriosis, and prostate
cancer. The company is also developing MVT-602, an oligopeptide
kisspeptin-1 receptor agonist that has completed a Phase 2a study
for the treatment of female infertility as part of assisted
reproduction. Takeda Pharmaceuticals International AG, a
subsidiary of Takeda Pharmaceutical Company Limited, the originator
of relugolix, previously granted the company a worldwide
license to develop and commercialize relugolix
(excluding Japan and certain other Asian countries) and
an exclusive license to develop and commercialize MVT-602 in all
countries worldwide. Sumitovant Biopharma, Ltd., a wholly
owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is the
majority shareholder of Myovant. For more information, please
visit the company’s website at www.myovant.com.
Follow @Myovant on Twitter and LinkedIn.
Media contact on behalf of Forward Momentum:
Albert Liao Director, Corporate Communications Myovant
Sciences, Inc. media@myovant.com
Myovant Sciences (NYSE:MYOV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myovant Sciences (NYSE:MYOV)
Historical Stock Chart
From Apr 2023 to Apr 2024